TABLE 2.
Disease | Probability | Source |
---|---|---|
Measles | 0.025 | 20 |
No complication | ||
Outbreak probability | 0.10 per year (every 10 years) | 21 |
Death (measles) | 0.001 | 4 |
Otitis | 0.03 | 4 |
Pneumonia | 0.045 | 4 |
Encephalitis | 0.001 | 4 |
Mumps | 0.017 | 20 |
No complication | ||
Outbreak probability | 0.05/year (every 20 years) | Personal communication† |
Death (mumps) | 0 | Data on file* |
Encephalitis | 0.0015 | 3 |
Orchitis | 0.05 | Data on file* |
Meningitis | 0.001 | 3 |
Deafness | 0.000005 | 3 |
Rubella | 0.005 | 20 |
No complication | ||
Outbreak probability | 0 | 19 |
Death (rubella) | 0 | Data on file* |
Abortion | 0 | 19 |
Congenital rubella syndrome | 0.000045 (18 cases/400,000) | Personal communication† |
Cardiac malformations | 0.46 | 22 |
Deafness | 0.87 | 22 |
Eye problems | 0.34 | 22 |
Mental retardation | 0.39 | 22 |
Thrombocytopenia | 0.00033 | 3 |
Arthritis | 0.19 | Data on file*, 20 |
Vaccination | ||
Vaccine failure | ||
Mumps | 0.10 | 20 |
Measles | 0.08 | 20 |
Rubella | 0.02 | 20 |
Fever | 0.1 | 23 |
Rash | 0.1 | 23 |
Anaphylaxis | 0.00001 | Data on file* |
Merck Frosst Canada Inc.
Gaston de Serres, Centre de santé publique due Québec, Québec, Québec